WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 23-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 11'7601 Infant (under 12 months) mortality rate: 152
GDP / capita (US$): 16'1551 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 207'848  206'078  204'259  202'402  200'518  175'786  150'393  122'200 
Births 3'016  3'035  3'051  3'066  3'080  3'676  3'646  3'938 
Surviving infants 2'961  2'977  2'991  3'002  3'014  3'562  3'469  3'630 
Pop. less than 5 years 15'032  15'022  14'915  14'839  14'981  17'624  17'853  17'251 
Pop. less than 15 years 47'862  48'484  48'981  49'394  49'842  52'174  53'201  46'872 
Female 15-49 years 56'749  56'410  56'099  55'795  55'444  49'028  39'291  30'501 

Number of reported cases

(Click for retrospective incidence data for Brazil)
Diphtheria
ChartChart
  12  46  640  4'646 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  214  876  220  43  36  61'435  99'263 
Mumps
ChartChart
 
Pertussis
ChartChart
  2'920  8'338  5'211  5'400  2'257  764  15'329  45'752 
Polio*
ChartChart
  1'342 
Rubella
ChartChart
  8'781 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  34  298 
Tetanus (total)**
ChartChart
  273  273  213  314  333  346  1'547  3'098 
Yellow fever
ChartChart
  85  27 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Brazil)
Vaccine year result method % card seen                                                
BCG 1995  93  DHS   79  99*  99*  99*  99*  99*  99*  79  56 
DTP1 1995  95  DHS   79  99*  99*  99*  99*  99*  99* 
DTP3 1995  81  DHS   79  95  93  97  95  99*  98  66  37 
DTP4          85  85 
IPV1          98  99* 
HepB_BD          89  88  39  99* 
HepB3          95  96  99*  96  98  94 
Hib3          95  95  98  94  99*  90 
JapEnc         
MCV1          95  97  99*  97  99*  99*  78  57 
MCV2          79  96  99*  96  99*  95 
PCV1          99*  99  97  99* 
PCV3          93  93  94  88  82 
Pol3 1995  81  DHS   79  99*  96  99*  96  99*  99*  58  69 
Rota1          93  91  99  97 
RotaC         
Rubella1          95  99*  99*  99  99* 
TT2plus 1995  45  DHS   79  40  38  54  34  99* 
PAB         
VAD1         
YFV          83  99*  99*  99*  99*  99* 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Brazil)
BCG
ChartChart
  99  99  99  99  99  79  56 
DTP1
ChartChart
  99  99  99  99  99  86  62 
DTP3
ChartChart
  93  97  95  99  98  66  37 
HepB3
ChartChart
  96  96  96  98  94 
HepB_BD
ChartChart
  88  89  90  91  99 
Hib3
ChartChart
  95  98  94  99  90 
MCV1
ChartChart
  97  97  97  99  99  78  57 
MCV2
ChartChart
  96  99  96  75  95 
PAB
ChartChart
  93  93  93  92  92  63 
PCV3
ChartChart
  93  94  88  82 
Pol3
ChartChart
  96  96  96  98  99  58  69 
RotaC
ChartChart
  92  93  86  87 
YFV
ChartChart
  45  44  42  37  37 

Number of districts in the country 5'570  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 72
From 80 to 89% 12
From 50 to 79% 13
Less than 50% 3
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
CHOLERA >= 18 years (x2 doses); Yes Military
DT 2, 4, 6 months; Yes risk groups
DTaPHepBIPV private sector
DTaPHibHepIPV private sector
DTwP 15 months; 4 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV 9-26 years; +6 months; Yes
HepA 15 months; Yes for risk groups
HepB_Adult >= 7 years (x3 doses); Yes
HepB_Pediatric birth; Yes
Hib 2, 4, 6 months; Yes Special groups
IPV 2, 4 months; Yes and a dose at 6 months for risk groups
Influenza_Adult >= 9 years; Yes and adults with chronic diseases, pregnant women, health care workers and other risk groups
Influenza_Pediatric 6 months to 5 years (x2 doses); Yes and chronic diseases
MMR 12 months; Yes
MMRV 15 months; Yes
MenACWY private sector
MenB private sector
MenC_conj 3, 5, 12 months; Yes '
OPV 6, 15 months; 4 years; Yes
Pneumo_conj 2, 4, 6, 12 months; Yes
Pneumo_ps 5 years; Yes elderly and risk groups
Rotavirus 2, 4 months; Yes
Td 1st contact; +2, +4 months; Yes >7 years
Tdap Yes For each pregnancies (between week 27 to 36)
Varicella 15 months; Yes if not given in combination vaccine with MMR
YF 9 months; 4 years; No where indicated

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   2011-2016  2011-2015    2008-2011  2008-2011  2008-2011 
Nº of districts with microplans that include activities to raise immunization coverage number   5'567  5'565      5'565  5'564 

System performance

Total Nº districts in country number 5'570  5'565  5'565  5'565  5'565  5'565  5'564 
Nº districts with DTP3 coverage >=80% number 4'639  4'658  4'616  4'950  4'951  5'140  4'901 
% of districts with DTP3 coverage >=80% From 0 to 100% 83  84  83  89  89  92  88 
Nº districts with measles (MCV1) coverage >=95% number 4'284  4'194  3'413  3'369  3'354  3'872  3'365 
% of districts with MCV1 coverage >=95% From 0 to 100% 77  75  61  61  60  70  60 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.